Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19

National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19

March 17, 2020NewsCOVID-19, virusbiolabs

Nebraska is conducting the first clinical trial of possible coronavirus treatment, which is expected to eventually include 400 patients in 50 locations around the world, officials said. In this international study, halfRead More…

Summary of New Drugs with Clinical Trial Progress Approved by FDA in 2019

January 15, 2020Drug Discovery Research, NewsAntibiotics, Diagnostic Reagents, New Drugs, Targeted Drugsbiolabs

Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…

Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy

December 18, 2019Immunotherapy Researchcell therapy, immunotherapy, T cellbiolabs

In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…

A New Antibody is Expected to be Developed as a General Influenza Vaccine

November 7, 2019Drug Discovery ResearchAntibody Discovery, Therapeutic Antibody, virusbiolabs

A team of researchers from the United States have found that an antibody that “embeds” influenza virus surface proteins can protect mice from a variety of influenza virus strains and is expectedRead More…

Comprehensive Analysis of Targeted Drugs for Lung Cancer

October 11, 2019Drug Discovery Research, Immunotherapy Research, Newsimmunotherapy, monoclonal antibody, Small molecule targeted drugsbiolabs

Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…

Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation

September 17, 2019Antibody Engineering Research, NewsCell Characterization, Nanotechnology, Stem Cell Transplantationbiolabs

In a study published in the international journal ACS Nano, scientists from Rutgers University have developed a new nanotechnology. It may accelerate the research in the field of stem cell transplantation andRead More…

How to Develop Immunotherapeutic Drugs?

August 6, 2019Drug Discovery Research, Immunotherapy ResearchCAR-T, immunotherapy, Therapeutic Antibodybiolabs

The high cost of cancer drugs makes it difficult for public and private health care systems to provide patients with up-to-date treatment. If this trend continues, it will be increasingly difficult forRead More…

Antibody Drugs and Cell Therapy for Tumor Microenvironment

July 16, 2019Antibody Engineering Research, Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, CAR-T, immunotherapy, Tumor Microenvironmentbiolabs

According to the World Health Organization (WHO), cancer is the second leading cause of death in the world. In 2018 alone, 9.6 million people worldwide died of cancer, accounting for about 1/6Read More…

Monoclonal Drug Development and Market Conditions

June 19, 2019Biological Knowledge, Newsantibody development, Antibody Discovery, monoclonal antibody, Therapeutic Antibodybiolabs

B lymphocytes can only produce a proprietary antibody against an antigen determinant, so it has the characteristics of highly specific physical and chemical properties, single biological activity, strong binding specificity with antigenRead More…

Focus on the Technology Bottleneck of Monoclonal Antibody Drugs

May 30, 2019Antibody Engineering Research, Biological Knowledge, Drug Discovery Researchantibody development, Humanized Antibody, monoclonal antibody, Therapeutic Antibodybiolabs

The Antibodies are secreted by plasma cells transformed from B cells, and each B cell line can produce only one specific antigenic determinant. The antibody, produced from a single cell line, isRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Nat Methods: How to Enhance the Effect of T Cell Therapy?
  • New TCR Therapy—Tebentafusp
  • eLife: The New Anticancer Mechanism of T Cells
  • The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine
  • COVID-19 May Lead to the Loss of Important Immune Structure—It Is Expected to Explain the Cause of Secondary Infection in Recovered Patients

Archives

Contact Us

USA:
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
Europe:
Tel: 44-207-097-1828

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext